XML 38 R30.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Basis of Presentation and Significant Accounting Policies - Schedule of Revenues consist of product sales to customers (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Disaggregation of Revenue [Line Items]        
Total revenues $ 241,963 $ 165,235 $ 447,794 $ 283,697
NUPLAZID        
Disaggregation of Revenue [Line Items]        
Total revenues 157,409 142,018 287,332 260,480
DAYBUE        
Disaggregation of Revenue [Line Items]        
Total revenues $ 84,554 $ 23,217 $ 160,462 $ 23,217